Thermo Fisher Scientific Inc. reported robust fourth-quarter 2025 results, with adjusted earnings per share of $6.57, beating estimates by 2.1%, and revenues of $12.22 billion, reflecting a 7.2% year-over-year growth. The company closed the quarter with $10.11 billion in cash, a substantial increase from the prior quarter, and initiated a 2026 revenue guidance of $46.3 billion to $47.2 billion, expecting 4% to 6% growth. These strong financials and a consistent dividend history underscore Thermo Fisher's solid position in the market.